Abstract
The Functional Assessment of Migraine Scale (FAMS) is a newly developed questionnaire that allows patients to indicate their response to migraine treatment [1]. The datasets provided in this article were collected on patients with migraine using survey methodology in two rounds of data collection. In the first dataset (n = 100), patients were shown 210 proposed questions for the FAMS and rated their usefulness and/or relevance for assessing their treatment response [2]. Using factor analyses, the best items were selected for the second data collection (n = 200). Patients completed the final proposed 72 items along with two other popular measures of migraine assessment [3]. Both datasets include demographic and migraine related information (gender, race, medication, number of headache and migraine days). These data provide a wealth of information about the number and types of medications a patient with migraine may take, coupled with information about their perceived response to treatment with those medications. Because the FAMS was developed to assess a wide range of concerns voiced by patients, this data offers new insights into a large health population beyond the normal scope of research studies.